Rajpathak, Swapnil

Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus

Iglay, K., Hannachi, H., Joseph Howie, P., Xu, J., Li, X., Engel, S. S., Moore, L. M., & Rajpathak, S. (2016) · Current Medical Research and Opinion

Chronic Disease Management StrategiesDiabetes Treatment and Management

Cited by 511

Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis

Rajpathak, S. N., Kumbhani, D. J., Crandall, J., Barzilai, N., Alderman, M., & Ridker, P. M. (2009) · Diabetes Care

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 439

The role of iron in type 2 diabetes in humans

Rajpathak, S. N., Crandall, J. P., Wylie-Rosett, J., Kabat, G. C., Rohan, T. E., & Hu, F. B. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects

Iron Metabolism and DisordersTrace Elements in Health

Cited by 363

Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes

Iglay, K., Cartier, S. E., Rosen, V. M., Zarotsky, V., Rajpathak, S. N., Radican, L., & Tunceli, K. (2015) · Current Medical Research and Opinion

Medication Adherence and ComplianceDiabetes Treatment and Management

Cited by 157

Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK

Weiss, T., Yang, L., Carr, R. D., Pal, S., Sawhney, B., Boggs, R., Rajpathak, S., & Iglay, K. (2022) · BMJ Open Diabetes Research & Care

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 152

Statin use and risk of developing diabetes: results from the Diabetes Prevention Program

Crandall, J. P., Mather, K., Rajpathak, S. N., Goldberg, R. B., Watson, K., Foo, S., Ratner, R., Barrett-Connor, E., & Temprosa, M. (2017) · BMJ Open Diabetes Research & Care

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 137

Real-World Adherence and Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes Mellitus Patients in the United States

Weiss, T., Carr, R. D., Pal, S., Yang, L., Sawhney, B., Boggs, R., Rajpathak, S., & Iglay, K. (2020) · Patient Preference and Adherence

Diabetes Treatment and ManagementMedication Adherence and Compliance

Cited by 126

Calcium and dairy intakes in relation to long-term weight gain in US men

Rajpathak, S. N., Rimm, E. B., Rosner, B., Willett, W. C., & Hu, F. B. (2006) · The American Journal of Clinical Nutrition

Nutritional Studies and DietNutrition and Health Studies

Cited by 116

Strategies for overcoming therapeutic inertia in type 2 diabetes: A systematic review and meta-analysis

Powell, R. E., Zaccardi, F., Beebe, C., Chen, X. M., Crawford, A., Cuddeback, J., Gabbay, R. A., Kissela, L., Litchman, M. L., Mehta, R., et al. (2021) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDiabetes Management and Education

Cited by 99

Secondary metformin monotherapy failure in individuals with type 2 diabetes mellitus

Weiss, T., Iglay, K., Gulati, T., Rajpathak, S., Yang, L., & Blonde, L. (2021) · BMJ Open Diabetes Research & Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 6